Shelia M. Violette

Shelia M. Violette

Company: Q32 Bio

Job title: Co-Founder, Chief Scientific Officer & President of Research


The Potential for Tissue Targeted Complement Inhibition: Generation of a Novel Therapeutic Platform 9:30 am

Download the event guide here for full session detailsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.